Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Metabolic Disease Suppliers In Europe
21 companies found
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
based inCambridge, MASSACHUSETTS (USA)
Alnylam is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life ...
based inAbercynon, UNITED KINGDOM
Imspex provides cutting-edge analytics solutions where early warning signals are needed. Our versatile combination of gas chromatography (GC) and ion mobility spectrometry (IMS) has already proven itself in medical detection and medical diagnosis ...
based inParis, FRANCE
Metabolism is the most fundamental force driving and sustaining life At Metafora, we leverage our knowledge and understanding of cellular metabolism to develop innovative and impactful solutions that change patients’ lives. At METAFORA, we are ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Metabolic disorders are a major cause of morbidity and mortality, representing a growing health concern worldwide. Over the last decade, substantial progress has been made in the discovery of genetic variants influencing a range of ...
based inCambridge, UNITED KINGDOM
Biochrom has a long history of making quality scientific instruments for a wide range of applications in the clinical, life-science and industrial markets.We are committed to remaining a world class company by the regular introduction of new, ...
Biochrom launches the Biochrom 30+ Series of amino acid analyzers - the gold standard in dedicated amino acid analysis. Clinical laboratories worldwide trust this well documented classical amino acid analysis method based on ion exchange ...
based inSchlieren, SWITZERLAND
Based on our research, we believe that the common denominator underlying each intestinal microbiome is a network of interconnected, interdependent and metabolic functions that are essential for the host and the microbiome. PharmaBiome has developed ...
The human microbiome fulfills a variety of functions. Each function is ascribed a set of bacteria, and these all have various functions under different circumstances. A bacterial consortium needs to be versatile, balanced and cover all the essential ...
based inKiel, GERMANY
QuantView GmbH specializes in advancing MRI technology through revolutionary signal amplification methods, utilizing a quantum mechanical technique for enhanced image resolution. By focusing on hyperpolarized MRI technology, QuantView significantly ...
based inLiège, BELGIUM
ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for the screening of rare, genetic, chronic or infectious metabolic diseases in human ...
based inTübingen, GERMANY
HepaRegeniX GmbH is a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases. Since its start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment ...
Liver diseases are characterized by a gradual deterioration of the liver function, and, on a molecular level, by a reorganization and destruction of liver tissue. Several disease stages characterize the path from the healthy liver to a fully ...
based inLabège, FRANCE
Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...
Bacterial translocation: the missing link between intestinal microbiome and human complex non-communicable diseases. Complex disorders are multifactorial and often chronic, caused by genetic and environmental factors and ...
based inPlan-les-Ouates, SWITZERLAND
Adiposs is a biotech start-up company, a spin-off from the University of Geneva. The company is incorporated in the Canton of Geneva, Switzerland. Adiposs is developing first-in-class medical imaging products and technologies. Adiposs has developed ...
Adiposs has developed ImageBAT, the first product that makes brown and beige adipose tissue (BAT) visible with a fast and pain-free CT scan. It enables early detection of body wasting before patients lose body weight. The diagnostic procedure with ...
based inBalerna, SWITZERLAND
APR Applied Pharma Research s.a. (APR) is a Swiss Pharma company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life. Our focus as a Swiss global health care company is ...
GOLIKE PLUS 16+ is a Food for Special Medical Purposes in granules for oral use consisting of a prolonged-released amino-acid mixture without phenylalanine, with vitamins, minerals and other nutrients. It is gluten and lactose ...
based inRoyston, UNITED KINGDOM
Volac is a fast-growing, ambitious international business and we are world leaders in dairy nutrition. We are a family-owned business and have been producing high-performance dairy nutritional products for over fifty years. We passionately believe ...
based inHergiswil, SWITZERLAND
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of ...
based inLondon, UNITED KINGDOM
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, ...
based inLoos, FRANCE
GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases. Our translational disease-driven research approach is based on strong expertise, featuring in-house knowledge of ...
based inDijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
Faecalibacterium prausnitzii (F. prau), a key bacterium to treat Crohn’s Disease Meet Faecalibacterium prausnitzii (F. prau) WHAT IS F. prau? F. prau, is a dominant member of the healthy gut microbiome. It accounts for 5% to 15% of the total ...
based inSchlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...